Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HCA HEALTHCARE, INC.

(HCA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

HCA Healthcare : BofA Securities Adjusts Price Target for HCA Healthcare to $260 From $242, Maintains Buy Rating

06/15/2021 | 02:56pm EDT


© MT Newswires 2021
All news about HCA HEALTHCARE, INC.
07/30HCA HEALTHCARE : Insider at HCA Healthcare (HCA) Makes Significant Sale of Stock
MT
07/29INSIDER TRENDS : Insider 90-Day Selling Trend Extended at HCA Healthcare
MT
07/29INSIDER TRENDS : HCA Healthcare Insider Exercises Options Derivative Securities,..
MT
07/28GALEN COLLEGE OF NURSING : Opens New Campus in Austin, Texas
PR
07/27HCA HEALTHCARE : Appoints Hugh F. Johnston as New Independent Director (Form 8-K..
PU
07/27HCA HEALTHCARE, INC. : Change in Directors or Principal Officers, Financial Stat..
AQ
07/27HCA HEALTHCARE : Appoints Hugh F. Johnston as New Independent Director
BU
07/27Hca Healthcare Appoints Hugh F. Johnston as New Independent Director, Effecti..
CI
07/26INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at HCA Healthcare
MT
07/23INSIDER TRENDS : HCA Healthcare Insider Exercises Option/Derivative Security for..
MT
More news
Financials (USD)
Sales 2021 57 689 M - -
Net income 2021 5 596 M - -
Net Debt 2021 33 022 M - -
P/E ratio 2021 14,7x
Yield 2021 0,92%
Capitalization 82 069 M 82 069 M -
EV / Sales 2021 2,00x
EV / Sales 2022 1,89x
Nbr of Employees 235 000
Free-Float 78,7%
Chart HCA HEALTHCARE, INC.
Duration : Period :
HCA Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCA HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 248,20 $
Average target price 259,95 $
Spread / Average Target 4,74%
EPS Revisions
Managers and Directors
Samuel N. Hazen President, CEO, Chief Operating Officer & Director
William B. Rutherford CFO, Chief Accounting Officer & Executive VP
Thomas Fearn Frist Chairman
Jonathan B. Perlin Chief Medical Officer
P. Martin Paslick Chief Information Officer & Senior Vice President